Literature DB >> 12429940

SUMO-1 and p53.

Frauke Melchior1, Ludger Hengst.   

Abstract

Abundance and activity of the tumor suppressor p53 are regulated by many different posttranslational modifications. These include phosphorylation, acetylation, ribosylation, O-glycosylation or ubiquitination. Three years ago, covalent modification with the ubiquitin- related protein SUMO-1 has been added to this list. SUMO-1 resembles ubiquitin both in structure and in the mechanism of attachment, and is reversibly attached to a large number of proteins. Molecular consequences of this dynamic modification vary between targets and include alterations in protein/protein or protein/DNA interactions, changes in localization, enzymatic activity, or stability. A role of SUMOylation in modulating p53 transcriptional activity has been reported, but is still an issue of controversy. Here we will briefly summarize the pathway of SUMOylation and discuss possible implications for p53 function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429940

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  35 in total

1.  The SUMO conjugation pathway in Populus: genomic analysis, tissue-specific and inducible SUMOylation and in vitro de-SUMOylation.

Authors:  Jon M Reed; Christopher Dervinis; Alison M Morse; John M Davis
Journal:  Planta       Date:  2010-04-02       Impact factor: 4.116

2.  SUMO-specific protease 2 in Mdm2-mediated regulation of p53.

Authors:  M Jiang; S-Y Chiu; W Hsu
Journal:  Cell Death Differ       Date:  2010-12-24       Impact factor: 15.828

3.  Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.

Authors:  Stergios J Moschos; Yin-Yuan Mo
Journal:  J Mol Histol       Date:  2006-06-07       Impact factor: 2.611

Review 4.  Ubiquitin and ubiquitin-like modifications of the p53 family.

Authors:  Ian R Watson; Meredith S Irwin
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

5.  Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

6.  Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent.

Authors:  Joshua F Heiber; Glen N Barber
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

7.  The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine.

Authors:  Chad Deisenroth; Yanping Zhang
Journal:  Genes Cancer       Date:  2011-04

8.  SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.

Authors:  An-Jing Chen; Lu Gao; Xian-Wei Wang; Xiao-Fan Zhao; Jin-Xing Wang
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.

Authors:  Amélie Fradet-Turcotte; Karine Brault; Steve Titolo; Peter M Howley; Jacques Archambault
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

10.  p53 sumoylation: mechanistic insights from reconstitution studies.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Epigenetics       Date:  2009-10-09       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.